Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection.

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Yang, C; Xie, M; Zhang, K; Liu, H; Liang, A; Young, KH; Qian, W

Published Date

  • November 2020

Published In

Volume / Issue

  • 34 / 11

Start / End Page

  • 3055 - 3059

PubMed ID

  • 32533094

Electronic International Standard Serial Number (EISSN)

  • 1476-5551

Digital Object Identifier (DOI)

  • 10.1038/s41375-020-0913-y

Language

  • eng

Conference Location

  • England